Regulus Therapeutics
RGLS
#9077
Rank
โ‚น8.45 B
Marketcap
โ‚น129.01
Share price
11.28%
Change (1 day)
-34.01%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2024 (TTM): -โ‚น3.46 Billion

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚น2.57 Billion a decrease over its 2022 earnings that were of -โ‚น2.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น3.46 Billion34.59%
2023 -โ‚น2.57 Billion6.51%
2022 -โ‚น2.41 Billion2.53%
2021 -โ‚น2.35 Billion93.59%
2020 -โ‚น1.22 Billion-15.41%
2019 -โ‚น1.44 Billion-64.46%
2018 -โ‚น4.04 Billion-33.26%
2017 -โ‚น6.05 Billion-13.98%
2016 -โ‚น7.04 Billion44.77%
2015 -โ‚น4.86 Billion-1.63%
2014 -โ‚น4.94 Billion203.6%
2013 -โ‚น1.63 Billion8.65%
2012 -โ‚น1.5 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น363.57 B-10,182.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น692.29 B-19,298.05%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น166.14 B-4,707.31%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น909.43 B-25,319.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
-โ‚น20.53 Billion 469.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น11.7 Billion 224.45%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น730.39 Billion 20,154.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น10.26 Billion 184.40%๐Ÿ‡บ๐Ÿ‡ธ USA